-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on TELA Bio, Lowers Price Target to $3

Benzinga·03/27/2026 13:36:58
Listen to the news
Citizens analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target from $5 to $3.